⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GILD News
Gilead Sciences Inc
Ivonescimab Included in FirstWord Pharma's "The Drugs That Will Shape 2026"
prnewswire.com
AZN
NVS
MRNA
GILD
NVO
PFE
App Test Automation Industry Research 2026 - Global Market Size, Share, Trends, Opportunities, and Forecasts, 2021-2025 & 2026-2031
globenewswire.com
LOGI
MSFT
GOOG
AMZN
IBM
ORCL
INTC
NVDA
CRM
ADBE
SAP
EA
TTWO
ROKU
NFLX
DIS
CMCSA
TCOM
MELI
SHOP
PYPL
UBER
LYFT
DDOG
PANW
CRWD
ZS
NOW
TWLO
SNOW
PLTR
AI
STX
WDC
HPQ
DELL
HPE
QCOM
MRVL
AMD
MU
AMAT
LRCX
KLAC
ASML
GLW
AVGO
NXPI
TER
KEYS
NI
CHKP
FTNT
PPC
LULU
SIRI
BBY
TJX
LOW
HD
CAT
BA
GD
LMT
RTX
HON
GE
MMM
AXP
JPM
BAC
WFC
C
GS
MS
V
MA
PG
KO
PEP
MCD
SBUX
VZ
T
CHTR
TMUS
AMGN
BMY
PFE
JNJ
MRK
ABBV
LLY
GILD
BIIB
REGN
VRTX
AZN
SNY
NVS
XOM
CVX
SHEL
BABA
JD
NTES
PDD
EDU
TAL
BIDU
VIPS
CPRT
Gilead Sciences to Release Fourth Quarter & Full Year 2025 Financial Results on Tuesday, February 10, 2026
businesswire.com
GILD
RET Fusion Targeted Therapies Market Set for Robust Growth by 2034 Amid Precision Oncology Shift | DelveInsight
prnewswire.com
MRK
LLY
RIGL
AZN
GILD
ABBV
PFE
TMO
BMY
NVS
BIIB
Janux Therapeutics Appoints William Go, M.D., Ph.D., as Chief Medical Officer
businesswire.com
JANX
GILD
AMGN
2026年世界經濟論壇：隨著世界貿易的演變，沙烏地阿拉伯正在成為「連結經濟體」
businesswire.com
AMZN
GOOG
MSFT
NVDA
IBM
ORCL
CSCO
INTC
QCOM
AMGN
GILD
BMY
MRNA
PFE
JNJ
HON
GE
BA
LMT
GD
CD137 Targeted Therapy Research Report 2026-2030: 90 Therapies in Clinical Trials, Upcoming Commercial Launches, Global & Regional Clinical & Commercial Trends,
globenewswire.com
GILD
BMY
REGN
MRK
GENM
ABL
BNTX
BIIB
CD137 Targeted Therapy Research Report 2026-2030: 90 Therapies in Clinical Trials, Upcoming Commercial Launches, Global & Regional Clinical & Commercial Trends,
globenewswire.com
GILD
BMY
REGN
MRK
PFE
ABBV
BIIB
AZN
AMGN
NVS
GMAB
ABL
BNTX
Molecular Switch Targeting Therapies Market Research Report 2026: Opportunities in Targeted Drug Delivery Systems and Therapies in Oncology, Autoimmune, Inflammatory, and Neurological Disorders
globenewswire.com
MRK
BMY
AZN
PFE
NVS
LLY
JNJ
GSK
ABBV
REGN
VRTX
GILD
SNY
Molecular Switch Targeting Therapies Market Research Report 2026: Opportunities in Targeted Drug Delivery Systems and Therapies in Oncology, Autoimmune, Inflammatory, and Neurological Disorders
globenewswire.com
MRK
BMY
AZN
PFE
NVS
LLY
GILD
JNJ
REGN
ABBV
NVO
SNY
VRTX
AMGN
BIIB
INCY
EXEL
SRPT
CRSP
EDIT
NTLA
ALNY
MRNA
BNTX
COHR
IMUX
INSM
CYTK
KODK
LULU
NVDA
GOOG
MSFT
IBM
AMAT
ILMN
ALKS
ACAD
MNKD
TEVA
BHC
XBI
IBB
XLF
XLK
XLV
JAZZ
ACGL